Awareness and use of folic acid in the Netherlands:from science to practice by Walle, Hermien Evelien Klaaske de
  
 University of Groningen
Awareness and use of folic acid in the Netherlands
Walle, Hermien Evelien Klaaske de
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2001
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Walle, H. E. K. D. (2001). Awareness and use of folic acid in the Netherlands: from science to practice.
Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




Neural  tube defects (NTDs) and some other  severe congeni ta l  anomal ies are par t ly
preventable by the per iconcept ional  use of  fo l ic  ac id.  This thesis  descr ibes how sc ient i f ic
knowledge about  fo l ic  ac id was implemented in Dutch pol icy and analyses the ef fect  of
th is  pol icy.
Chapter 1 describes the results with respect to NTD prevalence (first part), and with
respect o the prevalence of other birth defects (second part) of controlled clinical trials
and observat ional  s tudies re lated to the use of  fo l ic  ac id supplements.  Al l  but  one study
showed that the risk of having a child with an NTD can be reduced by at least 5oo/o if
fo l ic  ac id supplements are taken per iconcept ionnal ly .  Most  s tudies were recurrence
studies us ing d i f ferent  doses of  mul t iv i tamins conta in ing fo l ic  ac id,  The ef f icacy of  4 mg
of  fo l ic  ac id in  women wi th a recurrence r isk was conclus ively  demonstrated by the MRC
trial in the UK, The Hungarian trial of Czeizel showed the same preventive effect for f irst
occurrences wi th fo l ic  ac id (800 pg)  taken as par t  of  a mul t iv i tamin.  In  a study on
Chinese women, Berry showed in 1999 a highly protective effect of 400 Ug of folic acid
alone on the NTD occurrence r isk.
The Hungarian study of Czeizel not only showed a protective effect on the occurrence of
NTDs but also on the occurrence of other birth defects. The second part of Chapter 1
describes tudies on possible protective effects of folic acid on the occurrence of
orofacial clefts, cardiac defects, urinary tract defects, and limb reduction defects. The
major i ty  of  these studies show a prevent ive ef fect  of  mul t iv i tamins conta in ing fo l ic  ac id.
Chapter  2 descr ibes how th is  sc ient i f ic  knowledge was implemented in the Dutch
si tuat ion.  Two of f ic ia l  repor ts  on th is  topic  were publ ished in 1992 and 1993.  Only
women wi th a pr ior  NTD pregnancy ( recurrence group) were advised to take 4 mg fo l ic
ac id p i l ls  per  day.  Women wi th a h igher  than normal  r isk because of  exposure to r isk
factors,  such as d iabetes mel l i tus or  epi lepsy,  were advised to take the same dose as
advised for  women wi th a normal  populat ion r isk;  that  is  400 pg of  fo l ic  ac id per  day.
Since the consumpt ion of  fo l ic  ac id-r ich food is  not  enough to reach,  at  populat ion level ,
a suf f ic ient  level  of  fo l ic  ac id dur ing pregnancy,  the repor t  advised to consume foods
for t i f ied wi th fo l ic  ac id.  Regulat ions in  the Nether lands,  however,  do prohib i t  such a
fortif ication. An effect of food fortif ication with folic acid could be masking pernicious
anaemia,  thus delay ing the d iagnosis of  a v i tamin Brz def ic iency.  Al though the repor t
concluded that  there were no speci f ic  groups in  the Dutch populat ion who would be at
extra risk for a vitamin Brz deficiency if food were fortif ied with folic acid, food
for t i f icat ion was not  a real  opt ion at  that  t ime.  Instead,  a l l  women of  ch i ldbear ing age
were advised to take a 0.5 mg fo l ic  ac id p i l l .  The main problem wi th fo l ic  ac id
supplementat ion is to reach the target  group suf f ic ient ly  in  t ime to take fo l ic  ac id for  at
least  four  weeks before concept ion.  Therefore,  the Min is t ry  of  Heal th,  Wel fare,  and
Sports init iated a campaign in 1995 to reach and inform this target group. Apart from
the nat ional  campaign,  there was a lso a regional  campaign,  in  which extra at tent ion was
given to reach women with a lower socio-economic status, because they are more
diff icult to reach and because NTDs are more prevalent among them.
Chapter 3 describes the method and results of the campaign in two national surveys.
Pregnant  women at  thei r  f i rs t  or  second antenata l  v is i t  to  the obstet r ic ian,  general
practit ioner or midwife were asked to fi l l  out a questionnaire. Level of education was
used as an indicator  of  socio-economic status,  Before the campaign,  an increase of
knowledge so as to match the level of knowledge of adverse effects of alcohol and
smoking was considered adequate - that  is ,  7Oo/o f  women planning a pregnancy should
know about  the advice and 65Vo of  these women should use fo l ic  ac id appropr iate ly .
After the campaign, awareness and use of folic acid had increased considerably, both
for  lower and for  h igher  educated women. The resul ts  of  the surveys show that  the
knowledge criterion is met (in 1996, 77o/o had heard about folic acid before pregnancy),
but  th is  is  not  the case for  the use cr i ter ion ( in  1996,  217o took fo l ic  ac id in  the advised
period). However, socio-economic differences in awareness and use of folic acid have
not significantly decreased. The effort made in the additional campaign to reach in
par t icu lar  lower educated women, d id not  resul t  in  reducing the d i f ferences between
groups of different socio-economic status, To the contrary of its target, media attention
focused on the lower educated group benef i ted the h igher  educated group more.
Reasons for not taking folic acid were either not thinking about it or a too late
awareness to be able to s tar t  in  t ime.
In 1998 and 2000,  two fo l low-up studies were per formed in the Northern Nether lands.
Chapter 4 describes the results. Since the level of knowledge (before pregnancy) was
already high in the survey of 1996, it was not surprising that thls remained constant at
about  75olo in  la ter  years.  In  1998,  the socio-economic d i f ferences in  knowledge wi th
respect to the advised period for taking folic acid had increased. In 2000, the
percentage of  women who knew th is  advised per iod decreased.  Media was the most
important  source for  obta in ing in format ion about  fo l ic  ac id.  In  the fo l low-up studies,  the
use of folic acid in the advised period increased to 360lo for both studies while socio-
economic d i f ferences remain ing stable.  The four  surveys show that  appropr iate use of
folic acid never exceeds 50o/o, not even for higher educated women. This is unexpected
especia l ly  s ince the Nether lands is  a country wi th a very h igh percentage of  p lanned
pregnancies. The conclusion is that in order to reduce the NTD risk for all women
for t i f icat ion of  food wi th fo l ic  ac id should be invest igated.  This in  combinat ion wi th a
structura l  campaign promot ing fo l ic  ac id and informing women about  the r ight  per iod to
take i t .
Chapter  5 deals wi th the f ina l  goal  of  the fo l ic  ac id publ ic  campaign,  namely the
reduction of the prevalence of NTDs and possible other birth defects. The Northern
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Netherlands (NNL) EUROCAT registry was used to investigate this. In Chapter 5.1 a
methodological exercise is described attempting to estimate the expected prevalence of
defects had the supplementation of folic acid never been introduced. A model was built
to estimate the prevalence of NTDs and other folic acid sensitive defects (FASDs).
FASDs are defined as NTDs and orofacial clefts, conotruncal heart defects, urinary tract
defects and limb reduction defects. The total prevalence over the years 1981-1995 was
used as the base- l ine prevalence to est imate the prevalence for  the years 1996-1999.
The results of the model show to be dependent on the used cut-off point i.e. the last
year  inc luded in the model .  This  is  main ly  due to insuf f ic ient  in format ive years.  As a
consequence, the model may be unstable, However, it is clear from the results in
chapter  5.1 that  in  the Northern Nether lands wi th 20,000 newborns per  year  and 35o/o
of women taking folic acid, it is very diff icult to detect a significant decrease of a rare
birth defect such as NTD. For FASDs this detection wil l be easier since the prevalence is
h igher  and does not  f luctuate as much as the NTD prevalence.
This is  the reason why in chapter  5.2 a case contro l  s tudy analys is  is  per formed using
the EUROCAT NNL data to investigate the possible preventive effect of folic acid in the
FASD group, The study showed a significant reduction in risk of heart defects and a
strong indication for a reduction in the prevalence of urinary tract defects.
F inal ly ,  chapter  6 d iscusses fur ther  implementat ion of  s t rategies to improve fo l ic  ac id
intake.  The resul ts  of  the surveys descr ibed in th is  thesis  imply socio-economic
differences with respect to the prevalence of NTDs and the intake of folic acid. There are
three possible pathways to increase the amount of folic acid. Firstly, by eating more folic
acid rich-foods. However, several studies have shown that this is a relatively ineffective
way compared with food fortif ied with folic acid. This is probably due to the fact that the
synthet ic  form of  the v i tamin is  more stable and more b ioavai lable.  I t is  est imated that
the bioavailabil ity of natural food folate is approximately 500/o. The second pathway is
by supplementat ion;  th is  is  the current  s t rategy in  the Nether lands.  This thesis  shows
that  i t  is  not  enough to have a h igh percentage of  p lanned pregnancies and a posi t ive
attitude towards folic acid to make this strategy a success, The last option is to fortify
food with folic acid. This is common practice in most European countries where mostly
cereal grain products are fortif ied. In the USA, enriched flour is fortif ied with 140 pg
fo l ic  ac id per  100 g s ince 1998.  In the UK, the government  is  advised to fo l low the same
strategy but  wi th a h igher  amount  of  fo l ic  ac id:  240 pgl100 9,  A r isk of  excessive in take
of  fo l ic  ac id is  that  i t  may mask pernic ious anaemia,  a v i tamin Brz def ic iency.  But
nowadays,  th is  anaemia can be d iagnosed by determinat ion of  812 in serum, Apart  f rom
helping to prevent serious birth defects, food fortif ied with folic acid may also help to
reduce arteriosclerotic vascular disease by reducing homocysteine levels. However,
there are no studies that directlv relate dietarv folate to the occurrence of vascular
d isease.
Since this thesis shows that socio-economic differences with respect to the use of folic
acid are increasing, the option of fortif ication must be seriously considered. It is
therefore disappointing that a recent report of the Dutch Health Council concludes to
only for t i fy  products especia l ly  a imed at  women who want  to become pregnant .  Noth ing
is  said about  what  k ind of  products to th ink of ,  or  the amount  of  fo l ic  ac id to be added.
If food fortif ication is not feasible in the nearby future, then the information on foiic acid
to a l l  women of  ch i ldbear ing age has to be in tensi f ied and has to be st ructura l .  The
media are important, but this thesis showed that health care professionals play an
important role as well. In particular lower educated women are relying on the advice of
their general practit ioner. The right t ime to start with folic acid, at least four weeks
before conception, should be stressed more. Finally, since the sensitive period in
embryonic development for some birth defects is longer than for NTDs, this thesis
recommends extending the postconceptional period of taking folic acid to at least three
months of  pregnancy.
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